eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
2/2021
vol. 37
 
Share:
Share:
Case report

Beneficial effect of lithium in female patient with bipolar affective illness and psoriasis

Przemysław Filipiak
1
,
Anna Jaskóła
1
,
Karolina Gattner
1

  1. HCP Medical Centre, Poznań
Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (2), 165–171
Online publish date: 2021/12/07
Article file
Get citation
 
PlumX metrics:
 
1. Alda M, Cavazzoni P, Grof P. Treatment response to prophylactic lithium and family history of psychiatric disorders. Biol Psychiatry 1999; Apr 15; 45(8): 1078. DOI: 10.1016/s0006-3223(98)00314-x. PMID: 10386197.
2. Blier P, Slater S, Measham T, Koch M, Wiviott G. Lithium and clozapine-induced neutropenia/agranulocytosis. Int Clin Psychopharmacol 1998; 13: 137-140.
3. Brauchli YB, Jick SS, Curtin F, Meier CR. Lithium, antipsychotics, and risk of psoriasis. J Clin Psychopharmacol 2009; 29: 134-140.
4. Carter TN. The relationship of lithium carbonate to psoriasis. Psychosomatics 1972; 13: 325-327.
5. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
6. D’Onofrio S, Mahaffey S, Garcia-Rill E. Role of calcium channels in bipolar disorder. Curr Psychopharmacol 2017; 6: 122-135.
7. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007; 25: 606-615.
8. Grof P. Excellent lithium responders: People whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW (Ed.). Lithium: 50 years of psychopharmacology, new perspectives in biomedical ;Cheshire: Weidner Publishing Group, 1999:36‐51.
9. Jabłońska S, Majewski S. Choroby skóry i choroby przenoszone drogą płciową; Wydawnictwo Lekarskie PZWL, wyd. 1 , Warszawa 2002.
10. Jaeschke R. Kompendium psychofarmakoterapii. Część 5: Lit. Charakterystyka ogólna, farmakokinetyka, mechanizmy działania, praktyka kliniczna; Medycyna Praktyczna; Psychiatria; 2018; 2: 27-42.
11. Jafferany M. lithium and psoriasis: what primary care and family physicians should know. Prim Care Companion J Clin Psychiatry 2008; 10: 436-439.
12. Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol 2010; 3(1): 32-38.
13. Nenman A, Adamski Z. Aspekty kliniczne i epidemiologiczne zaburzeń ogólnoustrojowych u chorych na łuszczycę. Forum Medycyny Rodzinnej 2009; 3: 447-453.
14. Ockenfels HM, Nussbaum G, Schultewolter T, Mertins K, Wagner SN, Goos M. Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. Dermatology 1995; 191: 217-225.
15. O’Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 2006; 5: 426-32.
16. Remlinger-Molenda A, Wójciak P, Michalak M, Rybakowski J. Ocena aktywności wybranych cytokin w epizodzie maniakalnym i depresyjnym choroby afektywnej dwubiegunowej. Psychiatr Pol 2012; 46: 599-611.
17. Rybakowski J. Neuroimmunologia zaburzeń psychicznych. W: Bilikiewicz A, Pużyński S, Rybakowski J, Wciórka J (red.). Psychiatria, t. 1. Urban & Partner, Wrocław 2002: 208.
18. Rybakowski J. Lit – niezwykły lek w psychiatrii; Termedia 2019, Poznań.
19. Rybakowski JK, Chłopocka-Woźniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord 2001; 3(2): 63-67.
20. Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983 143: 42-50.
21. Skoven I, Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol 1979; 115: 1185-1187.
22. Świerkosz A, Siwek M, Dudek D. Wpływ terapii litem na występowanie zmian opryszczkowych – opis przypadku. Farmakoterapia w Psychiatrii i Neurologii 2016; 32; 255-261.
23. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Am J Clin Dermatol 2000; 1: 159-165.

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.